Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV608 in Idiopathic Detrusor Overactivity
NCT00335660Phase 2Terminated
- Sponsor
- Avera Pharmaceuticals
- Start
- Jun 2006
- Primary completion
- Jun 2007
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of vestipitant in overactive bladder syndrome (OAB), sponsored by Avera Pharmaceuticals. Started Jun 2006; status: terminated.
02
Drugs
vestipitant
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT00335660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335660.